(Q50698153)

English

Fiscalins: new substance P inhibitors produced by the fungus Neosartorya fischeri. Taxonomy, fermentation, structures, and biological properties.

scientific article published in April 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Fiscalins: new substance P inhibitors produced by the fungus Neosartorya fischeri. Taxonomy, fermentation, structures, and biological properties (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

0 references

1 reference

Neosartorya fischeri var. fischeri

1 reference

Aspergillus fischeri

1 reference

Neosartorya fischeri

1 reference

4-[(4-hydroxy-2-methyl-1-oxo-3,3a-dihydro-2H-imidazo[1,2-a]indol-4-yl)methyl]-1-propan-2-yl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione

1 reference

1 reference

4-(1H-indol-3-ylmethyl)-1-propan-2-yl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione

1 reference

Scequinadoline B

1 reference

(1S,4S)-4-[[(2R,3aR,4S)-4-hydroxy-2-methyl-1-oxo-3,3a-dihydro-2H-imidazo[1,2-a]indol-4-yl]methyl]-1-propan-2-yl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione

1 reference

(1S,4S)-4-[[(3aS,4R)-4-hydroxy-2,2-dimethyl-1-oxo-3,3a-dihydroimidazo[1,2-a]indol-4-yl]methyl]-1-propan-2-yl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione

1 reference

(1S,4S)-4-(1H-indol-3-ylmethyl)-1-propan-2-yl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione

1 reference

1 reference

4-[(4-hydroxy-2,2-dimethyl-1-oxo-3,3a-dihydroimidazo[1,2-a]indol-4-yl)methyl]-1-propan-2-yl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione

1 reference

author name string

S M Wong

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

L L Musza

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

G C Kydd

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

R Kullnig

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A M Gillum

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

R Cooper

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1993

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/46/4/46_4_545/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.46.545?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

545-553

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.46.545?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

WS9326A, a novel tachykinin antagonist isolated from Streptomyces violaceusniger No. 9326. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.45.1055

A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

Pyrrolomycin group antibiotics inhibit substance P-induced release of myeloperoxidase from human polymorphonuclear leukocytes

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.44.533

Synthesis and substance P receptor binding activity of androstano[3,2-b]pyrimido[1,2-a]benzimidazoles

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

Tryptoquivaline and tryptoquivalone, two tremorgenic metabolites of Aspergillus clavatus

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

Pharmacological properties of a potent and selective nonpeptide substance P antagonist

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

Tachykinin receptor types: Classification and membrane signalling mechanisms

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

Imidazo[4,5-b]quinoxaline cyanines as neurokinin antagonists

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

WS9326A, a novel tachykinin antagonist isolated from Streptomyces violaceusniger no. 9326. II. Biological and pharmacological properties of WS9326A and tetrahydro-WS9326A (FK224)

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.545

Identifiers

10.7164/ANTIBIOTICS.46.545

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7684734%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50698153&oldid=2127402276"